ChienYeh Biotech Investment Holding Co., Ltd. Announces Q1 2026 EPS of 0.13 NT Dollars

Key facts

  • ChienYeh Biotech Investment Holding Co., Ltd. Announces Q1 2026 EPS of 0.13 NT Dollars
  • ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.

Citation
ChienYeh Biotech Investment Holding Co., Ltd. Announces Q1 2026 EPS of 0.13 NT Dollars (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 8, 2026 at 08:00 (1631h 0m after Published)
  • 🤖 AI Analyzed: May 8, 2026 at 08:06 (6 min after Collected)
Company Code: 4164
Company Name: ChienYeh Biotech Investment Holding Co., Ltd.
Industry: Biotechnology and Medical
Period: 2026 Q1
Basic Earnings Per Share: 0.13 NT Dollars
Operating Revenue: 1.16 billion NT Dollars
Net Profit After Tax: 0.36 billion NT Dollars

Keywords: Financial Report, Biotechnology and Medical, EPS

FAQ

What are the key facts in this article?

ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.

What is the direct answer?

ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-4164-2026Q1 | March 1, 2026

Back to Newsroom (13)